Conversely, serum levels of both BMP9 and BMP10 were decreased in patients with cirrhosis compared to patients with pre-cirrhotic liver fibrosis, being associated with disease severity [17]; and a decreased concentration of circulating BMP9 was observed in patients with NAFLD [32]. Here, BMP10 is linked to metabolic dysfunction-associated steatotic liver disease.